Summary
- Current Price
- As of today, COAG price is $25.55, up +0.99% on
- Current Price All-Time High
- COAG price is currently -30.21% below its historical high of $36.61 set on
- Market Cap
- COAG current market cap is $1B, with unknown 1-year change
- PE Ratio
- COAG PE ratio is unknown
- Revenue
- COAG current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for COAG is on
Profile
| Metric | Value |
|---|---|
| Full Name | Hemab Therapeutics Holdings, Inc. |
| Ticker | NASDAQ: COAG |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | hemab.com |
| Employees | 59 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $25.55 | |
| Price, 1D Change | +0.99% | |
| $1B | ||
| - | ||
| - | ||
| 1.81 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$31.82 | ||
| EPS, 1Y Change | -31.22% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$31.82 | ||
| EPS Estimate | N/A | -$3.04 |
| EPS Est. Change | N/A | +90.46% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $25.55 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.04 | N/A | - | |
| -$2.33 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $25.55 | |
| $26.82 | ||
| $26.82 | ||
| - | ||
| - | ||
| -$0.34 | ||
| 1.81 | ||
| $2.03 | ||
| 38.08 | ||
| 59.95% | ||
| 100.50% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$31.82 | ||
| -$304.00K | ||
| - | ||
| -$70.12M | ||
| - | ||
| -$63.91M | ||
| - | ||
| -$69.82M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -2.05 | ||
| 18.03 | ||
| 18.03 | ||
| - | ||
| - | ||
| 0.55 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -6.01 | ||
| -59.09 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$176.64M | ||
| $185.49M | ||
| $194.78M | ||
| $192.55M | ||
| $371.42M | ||
| $10.68M | ||
| $361.43M | ||
| $693.00K | ||
| $5.73M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $63.91M | ||
| $69.82M | ||
| $304.00K | ||
| $10.49M | ||
| $304.00K | ||
| $0.00 | ||
| -$227.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$61.48M | ||
| -$81.48M | ||
| $156.30M | ||
| $16.00K | ||
| -$61.49M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | ||
| Jefferies | ||
| Goldman Sachs | ||
| Evercore ISI Group |
Analyst sentiment
Institutional ownership
Screeners with COAG
FAQ
What is the ticker symbol for Hemab Therapeutics Holdings, Inc.?
The ticker symbol for Hemab Therapeutics Holdings, Inc. is NASDAQ:COAG
Does Hemab Therapeutics Holdings, Inc. pay dividends?
No, Hemab Therapeutics Holdings, Inc. does not pay dividends
What sector is Hemab Therapeutics Holdings, Inc. in?
Hemab Therapeutics Holdings, Inc. is in the Healthcare sector
What industry is Hemab Therapeutics Holdings, Inc. in?
Hemab Therapeutics Holdings, Inc. is in the Biotechnology industry
What country is Hemab Therapeutics Holdings, Inc. based in?
Hemab Therapeutics Holdings, Inc. is headquartered in United States
When did Hemab Therapeutics Holdings, Inc. go public?
Hemab Therapeutics Holdings, Inc. initial public offering (IPO) was on May 1, 2026
Is Hemab Therapeutics Holdings, Inc. in the S&P 500?
No, Hemab Therapeutics Holdings, Inc. is not included in the S&P 500 index
Is Hemab Therapeutics Holdings, Inc. in the NASDAQ 100?
No, Hemab Therapeutics Holdings, Inc. is not included in the NASDAQ 100 index
Is Hemab Therapeutics Holdings, Inc. in the Dow Jones?
No, Hemab Therapeutics Holdings, Inc. is not included in the Dow Jones index
When does Hemab Therapeutics Holdings, Inc. report earnings?
The next expected earnings date for Hemab Therapeutics Holdings, Inc. is August 14, 2026
Data Sources & References
- COAG Official Website www.hemab.com
- COAG Profile on Yahoo Finance finance.yahoo.com/quote/COAG
- COAG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/coag